STEM CELL THERAPIES IN INDIA

Authors

  • John Karuvelil DHARMARAM VIDHYA KSHETRAM (DVK)

Keywords:

STEM CELL, Human Genome

Abstract

The successful completion of the Human Genome Project has
helped the medical/pharmaceutical field the most. The knowledge
received from the findings of this project has engaged equally
researchers, medical professionals, pharmaceutical companies and
governments.1 While many governments allocate huge funds into
stem cell research aimed at development of medicines with the hope
of finding cures for diseases that have eluded lasting cures through
conventional medicines or treatments, pharmaceutical companies
invest heavily into the field with the hope of making huge profits.

Author Biography

John Karuvelil, DHARMARAM VIDHYA KSHETRAM (DVK)

Rev. Dr John Karuvelil, SJ is a lecturer of Moral Theology at Jnana-Deepa
Vidyapeeth (JDV) in Pune. He has a Doctorate from Boston College (USA) in
Theology, and is specialized in Bio-Medical Ethics.

References

Human Genome Project Information, Medicine and the New Genetics, http:// www.ornl.gov/sci/techresources/Human_Genome/medicine/medicine.shtml.

Indo-Asian News Service (IANS), “Americans Flocking to India for Stem Cell Therapy,” IBN Live, May 28, 2012.

http://ibnlive.in.com/news/americans-flocking-to-india-for-stem-cell-therapy/ 262019-17.html.

Times News Network, “Stem Cell Therapy Infuses New Life in Them,” The Times of India, Nov. 13, 2013, http://timesofindia.indiatimes.com/city/ bangalore/Stem-cell-therapy-infuses-new-life-in-them/articleshow/25660947.cms.

Alka Sharma, “Stem Cell Research in India: Developments So Far,” Cell News, Nov. 22, 2006, http://www.geocities.com/ giantfideli/art/CellNEWS_Stem_Cells_India_Upd.html.

Press Trust of India, “ICMR to Fund Stem Cell Research,” Zee News, December 27, 2011, http://zeenews.india.com/news/health/health-news/icmr-tofund- stem-cell-research_15052.html.

Times News Network (TNN), “Vadodara Doctors, Scientists Get Department of Biotechnology Funds for Stem Cell Research,” The Times of India, Nov 9, 2013, http://articles.timesofindia.indiatimes.com/2013-11-09/vadodara/43853933 _ 1_stem-cells-shinya-yamanaka-john-gurdon.

Bryn Lander, Halla Thorsteinsdóttir et al., “Harnessing Stem Cells for Health Needs in India,” Cell Stem Cell 3, no. 1 (July 2008) 11-15, http://download.cell.com/cell-stem-cell/pdf/PIIS1934590908002944. pdf?intermediate=true.

Michael Fumento, “The Greatest Stem-Cell-Research Scam,” New York Times, July 15, 2009, http://nypost.com/2009/07/15/the-great-stem-cell research-scam/; Gene Tarne and David Prentice, “Playing Politics with Stem Cells,” American Thinker, August 8, 2010, http://www.americanthinker.com/2010/08/ playing_politics_with_stem_cel.html.

http://www.pharmabiz.com/ ArticleDetails.aspx?aid=73322&sid.

Ganapati Mudur, “India Invests Heavily in Genomics Research,” British Medical Journal 322 (March 2001).

Sunil K. Pandya, “Stem Cell Transplantation in India: Tall Claims, Questionable Ethics,” Indian Journal of Medical Ethics 5, no. 1 (Jan-Mar 2008).

National Institutes of Health resource for stem cell research, “Stem Cell Information,” http://stemcells.nih.gov/info/health.asp.

Pandya, “Stem Cell Transplantation in India,” 15; Chaitanya Stem Cell Center, Pune, http://chaitanyastemcell.com/; and Indo-Asian News Service (IANS), “Americans Flocking to India for Stem Cell Therapy.”

Mediescapes India, “India Stem Cell Research,” http://www.mediescapes. com/india-stem-cell-research.html.

Seema Kamdar, “In Stem Cells, India Goes Where US Can’t,” DNA News, 23 December 2005, http://www.dnaindia.com/report09.php?NewsID=1003763& CatID.

http://in.rediff.com/news/2005/nov/16stem.htm.

UNI (United News of India), “Government to Act against Clinic Using Stem Cell Therapy,” The Hindu, 23 January 2006, http://www.hindu.com/2006/01/23/ stories/2006012300720900.htm.

Staff Reporter, “ICMR Okays Stem Cell Research by AIIMS,” The Hindu, 5 April 2005, http://www.thehindu.com/2005/04/06/stories/2005040612771300.htm.

K.S. Jayaraman, “Indian Regulations Fail to Monitor Growing Stem-Cell Use in Clinics,” Nature 434, no. 7031 (March 2005).

Sandhya Srinivasan, “Rogue Research in the Guise of Stem Cell Therapy,” Infochange, March 2006, http://www.infochangeindia.org/features326.jsp.

Business Standard Reporter, “Indian BioTech Industry to Reach $10 bn Mark by 2015,” Business Standard, May 5, 2011, http://www.business standard.com/article/companies/indian-biotech-industry-to-reach-10-bn-mark-by-2015-111050 500005_1.html.

Shishir Prasad, “Stem Cell Research: Advantage India” Forbes India, Feb. 6, 2010, http://forbesindia.com/article/briefing/stem-cell-research-advantage-india/ 9892/1.

Nina Mehta, “Obama Stem Cell Policy Will Boost India R&D,” Business Week, 14 June 2009, http://www.businessweek.com/globalbiz/content/jun2009/gb20090614

_078251.htm.

K. Ghosh and D. Mohanty, “Teaching of Medical Genetics in the Medical Colleges of India — Way Ahead,” Indian Journal of Human Genetics 8, no. 2 (2002).

Michael Fumento, “The Greatest Stem-Cell-Research Scam,” New York Times, July 15, 2009. Available at: http://nypost.com/2009/07/15/the-great-stem cellresearch- scam/.

Indian Council of Medical Research Department of Health research & Department of Biotechnology (ICMR-DBT) Guidelines for Stem Cell Research (2012), New Delhi: ICMR, March 2012, http://icmr.nic.in/stem_cell_guidelines.pdf.

Biswarup Gooptu, “Startups Do Promising Work in Drug Development, Stem Cell Therapy and Advanced Diagnostics,” Times of India, Sept. 25, 2013. Available at: http://timesofindia.indiatimes.com/business/india-business/Startupsdo- promising-work-in-drug-development-stem-cell-therapy-and-advanceddiagnostics/ articleshow/23027927.cms.

Seema Singh, “Stem Cell Industry: The Battle Within,” Forbes India, Feb. 12, 2013. Available at: http:// forbesindia.com/article/real-issue/stem-cells-industry-the-battle-within/34697/1.

Ashok S. Bhattacharjya and Puneet K. Sapra. “Health Insurance in China and India: Segmented Roles for Public and Private Financing.” Health Affairs 27, no.

(July-Aug. 2008).

Sandhya Srinivasan, “India Being Projected as a Global Hub for Clinical Trials,” Infochange, Dec. 2005, http://infochangeindia.org/public-health/features/ india-is-being-projected-as-a-global-hub-for-clinical-trials.html.

Downloads

Published

2013-12-31

How to Cite

Karuvelil, J. (2013). STEM CELL THERAPIES IN INDIA. Asian Horizons, 7(04), 754–770. Retrieved from https://dvkjournals.in/index.php/ah/article/view/2731